Donna R. Cryer, J.D., is Chief Patient Officer and one of the founding partners of CryerHealth, a boutique consulting firm now entering its 15th year, a pioneer in the science of patient engagement. Mrs. Cryer is also the Founder of Global Liver Institute (GLI), the premier patient-driven nonprofit advocacy organization which continues to shape and define the field of liver health across five continents. Driven by her own journey through pediatric IBD, liver transplantation, and orthopedic complications of treatment, Mrs. Cryer has raised more than $30 million for liver health initiatives directly, and uses her business and legal acumen to de-risk investment, convening and facilitating more than 200 organizations towards collaborative multi-stakeholder agenda setting and action, building strategic approaches to therapeutic and diagnostic innovation, regulation, adoption and payment structures for best practices to optimize access, outcomes, and value.
Mrs. Cryer has extensive advisory experience for charitable corporate, and government entities, currently serving on the Board of Trustees for Sibley Memorial Hospital/Johns Hopkins Medicine. She has more than a dozen peer-reviewed publications across digestive, metabolic, and healthcare quality journals. Mrs. Cryer was on the Founding Board of the Center for Innovation and Value Research and member of ISPOR.
Her expertise and effectiveness in advancing the voice of patients have been recognized by the United States Congress and White House. She has received the American College of Gastroenterology (ACG) Disruptive Innovator Award, the Global Genes RARE Champions of Hope Founder’s Award and the American Association for the Study of the Liver (AASLD) Distinguished Advocacy Service Award. Health2.0 named her the Top 10 Patients Who Make an Impact, and PharmaVoice featured Mrs. Cryer as one of the100 Most Inspiring People.
Equipped with a BA from Harvard, JD from Georgetown University Law Center, and recent Certificate in AI in Healthcare from the MIT Sloan School of Business, Mrs. Cryer serves as a fierce advocate for the transformative potential of patient engagement in health policy, research, data, and system design.
